An investigation into the transdermal delivery of nifedipine

Pharmaceutica Acta Helvetiae

Volumn 71, Issue 4, 1996, Pages 253-258

  McDaid, D M ^a,b   Deasy, P B ^b  

^a Forest Laboratories Ltd   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Nifedipine; Transdermal drug delivery

Indexed keywords

CARBOXYMETHYLCELLULOSE; DODECYL SULFATE SODIUM; NIFEDIPINE; PROPYLENE GLYCOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; MALE; NONHUMAN; NUDE MOUSE; PARTITION COEFFICIENT; SKIN ABSORPTION; SKIN PENETRATION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CALCIUM CHANNEL BLOCKERS; MALE; MICE; MICE, INBRED HRS; NIFEDIPINE; SKIN ABSORPTION;

EID: 0030273431     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(96)00022-2     Document Type: Article

References (15)

1. Barry, B.W. (1983) Dermatological Formulations: Percutaneous Absorption. Dekker, New York, pp. 138-145.
2. Barry, B.W. (1987) Mode of action of penetration enhancers in human skin. J. Control. Rel. 6, 237-248.
3. Diez, I., Colom, H., Moreno, J., Obach, R., Peraire, C. and Domenech, J. (1991) A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharm. Sci. 80, 931-934.
4. Hasegawa, A., Taguchi, M., Suzuki, R., Miyata, T., Nakagawa, H. and Sugimoto, I. (1988) Supersaturation mechanism of drugs from solid dispersions with enteric coating agents. Chem. Pharm. Bull. 36, 4941-4950.
5. Hermann, P. and Morselli, P.L. (1985) Pharmacokinetics of diltiazem and other calcium channel entry blockers. Acta Pharmacol. Toxicol. 57, Suppl. 2, 10-20.
6. Kasting, G.B., Smith, R.L. and Cooper, E.R. (1987) Effect of lipid solubility and molecular size on percutaneous absorption. In Shroot, B. and Schaefer, H. (Eds.), Skin Pharmacokinetics, Skin Pharmacology. Vol. 1. Karger, Basel, pp. 138-153.
7. Kleinbloesem, C.H., van Brummelen, P., Danhof, M., Faber, H., Urquhart, J. and Breimer, D.D. (1987) Rate of increase in the plasma concentration of nifedipine as a major determinant of it's haemodynamic effects in humans. Clin. Pharmacol. Ther. 41, 26-30.
8. Knutson, K., Krill, S.L. and Zhang, J. (1990) Solvent-mediated alterations of the stratum corneum. J. Control. Rel. 11, 93-103.
9. Kohri, N., Miyazaki, K., Arita, T., Shimono, H., Nomura, A. and Yasuda, H. (1987) Rel. characteristics of nifedipine sustained-Rel. granules in vitro and in healthy subjects. Chem. Pharm. Bull. 35, 2504-2509.
10. Kondo, S. and Sugimoto, I. (1987) Enhancement of transdermal delivery by superfluous thermodynamic potential. 1. Thermodynamic analysis of nifedipine transport across the lipoidal barrier. J. Pharmacobio-Dyn. 10, 587-594.
11. Kurihara-Bergstrom, T., Knutson, K., De Noble, L.J. and Goates, C.Y. (1990) Percutaneous absorption enhancement of an ionic molecule by ethanol-water system in human skin. Pharm. Res. 7, 762-766.
12. Majeed, I.A., Murray, W.J., Newton, D.W., Otham, S. and Al-Turk, W.A. (1987) Spectrophotometric study of the decomposition kinetics of nifedipine. J. Pharm. Pharmacol. 39, 1044-1046.
13. Martindale, The Extra Pharmacopoeia (1993) 30th Ed., Pharmaceutical Press, London, pp. 374-380.
14. O'Neill, C.T. and Deasy, P.B. (1988) Development and evaluation using hairless mouse skin of a transdermal timolol product. Int. J. Pharm. 48, 247-254.
15. Robertson, D.R.C., Walker, D.G., Renwick, A.G. and George, C.F. (1988) Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br. J. Clin. Pharmacol. 25, 297-305.